Regenerative Medical Technology Group Inc. financial data

Symbol
RMTG, MSSV on OTC
Location
433 Plaza Real Suite 275, Boca Raton, FL
Fiscal year end
December 31
Former names
MESO NUMISMATICS, INC. (to 10/24/2024)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.2 % -78.2%
Debt-to-equity -111 % +31.1%
Return On Equity 42.8 % -7.32%
Return On Assets -329 % -336%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.5M shares +0.76%
Common Stock, Shares, Outstanding 12.5M shares +0.4%
Entity Public Float 613K USD 0%
Common Stock, Value, Issued 12.5K USD +0.4%
Weighted Average Number of Shares Outstanding, Basic 12.5M shares +0.4%
Weighted Average Number of Shares Outstanding, Diluted 12.5M shares +0.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.87M USD +38%
Cost of Revenue 892K USD +33.7%
General and Administrative Expense 763K USD +26.6%
Net Income (Loss) Attributable to Parent -10.2M USD -68.1%
Earnings Per Share, Basic -0.83 USD/shares -72.9%
Earnings Per Share, Diluted -0.83 USD/shares -72.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 579K USD
Inventory, Net 6.68K USD
Assets, Current 687K USD -46.2%
Property, Plant and Equipment, Net 360K USD +176%
Operating Lease, Right-of-Use Asset 108K USD +480%
Intangible Assets, Net (Excluding Goodwill) 208K USD -31.9%
Goodwill 1.68M USD -71.1%
Other Assets, Noncurrent 7.26K USD
Assets 3.05M USD -59.6%
Accounts Payable, Current 555K USD +48.3%
Accrued Liabilities, Current 7.36M USD +35.6%
Contract with Customer, Liability, Current 373K USD
Liabilities, Current 26.4M USD +92.9%
Operating Lease, Liability, Noncurrent 32.1K USD
Liabilities 28.9M USD +24.4%
Retained Earnings (Accumulated Deficit) -66M USD -18.2%
Stockholders' Equity Attributable to Parent -25.8M USD -64.7%
Liabilities and Equity 3.05M USD -59.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 108K USD +1494%
Net Cash Provided by (Used in) Financing Activities -9.85K USD -606%
Net Cash Provided by (Used in) Investing Activities -59.2K USD -978%
Common Stock, Shares Authorized 6.5B shares 0%
Common Stock, Shares, Issued 12.5M shares -11.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.56K USD +98.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 617K USD -49.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 118 USD
Deferred Tax Assets, Valuation Allowance 5.29M USD +19.7%
Operating Lease, Liability 108K USD +480%
Depreciation 233K USD +283%
Payments to Acquire Property, Plant, and Equipment 59.2K USD +978%
Lessee, Operating Lease, Liability, to be Paid 114K USD
Property, Plant and Equipment, Gross 170K USD
Operating Lease, Liability, Current 76.1K USD +308%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.14K USD -57.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 76.1K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.98K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.71K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.29M USD +19.7%
Additional Paid in Capital 40.2M USD +0%
Depreciation, Depletion and Amortization 76.6K USD +35.2%
Interest Expense 4.52M USD +2.66%